Финска -
Фински -
Fimea (Suomen lääkevirasto)
mesalazin orion 1000 mg enterotabletti
faes farma, s.a. - mesalazine - enterotabletti - 1000 mg - mesalatsiini
Финска -
Фински -
Fimea (Suomen lääkevirasto)
ocutifex 0.25 mg/ml silmätipat, liuos, kerta-annospakkaus
pharma stulln gmbh - ketotifen hydrogen fumarate - silmätipat, liuos, kerta-annospakkaus - 0.25 mg/ml - ketotifeeni
Финска -
Фински -
Fimea (Suomen lääkevirasto)
loratadine accord 10 mg tabletti
accord healthcare b.v. - loratadine - tabletti - 10 mg - loratadiini
Финска -
Фински -
Fimea (Suomen lääkevirasto)
ketazed 0.25 mg/ml silmätipat, liuos
horus pharma - ketotifen hydrogen fumarate - silmätipat, liuos - 0.25 mg/ml - ketotifeeni
Финска -
Фински -
Fimea (Suomen lääkevirasto)
suvaxyn parvo/e-amphigen injektioneste, emulsio
zoetis animal health aps - erysipelothrix rhusiopathiae, inactivated, strain b-7, serotype 2, porcine parvovirus, inactivated, strain s-80 - injektioneste, emulsio - inaktivoitu sian parvovirus -rokote + inaktivoitu erysipelothrix rokote
Финска -
Фински -
Fimea (Suomen lääkevirasto)
rabadrop oraalisuspensio
bioveta a.s. - rabies-virus live - oraalisuspensio
Европска Унија -
Фински -
EMA (European Medicines Agency)
teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - mahalaukun kasvaimet - antineoplastiset aineet - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
